Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing

Nephi in Podcasts

product

Nephi is a nasal spray product developed by ARS Pharmaceuticals for emergency treatment of allergic reactions.

Mentions Over Time

1 mentions
1 related entities

Related Entities

Mentions in Podcasts

Vanguards of Health Care by Bloomberg Intelligence
ARS Pharma’s Clinical Differentiation

The company is commercializing Nephi, which was approved August of last year, an epinephrine nasal spray for emergency treatment, including anaphylaxis.